Horizon Pharma (HZNP) Posts Q3 Loss of 39c/Share

Horizon Pharma (NASDAQ: HZNP) reported Q3 EPS of ($0.39), $0.29 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $4.12 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat